Fox Chase-Temple Health form collaboration with Accutest Research Labs in India

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

FOX CHASE CANCER CENTER – Temple Health formed a partnership with Accutest Research Laboratories for joint work on clinical trials.

The partnership aims to offer a research platform to conduct clinical trials in the United States, India, Southeast Asia and Latin America. Representatives of both organizations signed a non-binding memorandum of understanding on Nov. 10 in New Delhi.

Accutest was founded in 1998, and offers end-to-end services to pharmaceutical and biotechnology companies. Its services include phase I bioavailability/bioequivalence studies, phase II – IV clinical development services and biosimilars services, covering clinical operations, clinical data management, pharmacovigilance, and medical writing services.

YOU MAY BE INTERESTED IN

I write a weekly blog for Georgetown University’s Lombardi Comprehensive Cancer Center community. Here I share an updated version of a blog post I wrote in September 2024, now supplemented by some poems I have written over the years that inspired paintings by my wife Harriet Weiner, who is a much better artist than I am a poet or writer. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login